« Return to archives | Ethics/Regulatory

Pearl IRB, Trafalgar Ethics Board join forces

Thursday, July 28, 2011 11:50 AM

With the multi-center global clinical trials trend continuing to grow, the U.S. and Canada accounted for 60.5% of sponsored trials in 2010. To deliver integrated U.S.-Canada study reviews, Pearl IRB, based in Indianapolis, and Toronto-based Trafalgar Ethics Board have joined forces.

Clinical trials are often delayed for many reasons, including contract negotiations, budgeting issues and IRB reviews. “We strive to decrease site review times by integrating our processes to provide parallel U.S. and Canadian site reviews,” said Diana Caldwell, president and CEO of Pearl IRB. “Additionally, we will partner to offer additional services including medical writing, GCP/ICH assistance and site training, all of which reach across Canada and the U.S. now.”

“Both our Canadian clients and U.S.-based sponsors are demanding higher quality and increased efficiencies in the global regulatory oversight of their clinical trials,” added Ali Thompson, director of Trafalgar Ethics Board. “By working together to provide seamless U.S.-Canada IRB reviews, we eliminate much duplication and help streamline work for our clients.”

Share:          
CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.